Theralase Launches First Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study
TORONTO, ON / ACCESSWIRE / January 19, 2021 / Theralase® Technologies Inc. ("Theralase" or "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical...
A Year of Purpose and Progress: Dr. Christina Rahm Celebrates Global Growth, Scientific Breakthroughs, and International Honors